Ginkgetin delays the progression of osteoarthritis by inhibiting the NF-κB and MAPK signaling pathways
Abstract Background Osteoarthritis (OA) is considered an advancing chronic degenerative joint disease, leading to severe physical functional impairment of patients. Its development is closely related to increased inflammation and oxidative stress within the joint. Ginkgetin (GK), a natural non-toxic...
Saved in:
Main Authors: | Liang Zhu, Yanchi Bi, Ting Liang, Po Zhang, Xiao Xiao, Tengbo Yu |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2025-02-01
|
Series: | Journal of Orthopaedic Surgery and Research |
Subjects: | |
Online Access: | https://doi.org/10.1186/s13018-025-05525-5 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Investigating the mechanisms of ginkgetin-mediated reversal of cisplatin resistance in cervical cancer through network pharmacology and molecular docking approaches
by: Fei Wang, et al.
Published: (2025-02-01) -
Ginkgetin Alleviates Inflammation and Senescence by Targeting STING
by: Yadan Liu, et al.
Published: (2025-01-01) -
Bioinformatics-Based Exploration of the Ability of Ginkgetin to Alleviate the Senescence of Cardiomyocytes After Myocardial Infarction and Its Cardioprotective Effects
by: Li H, et al.
Published: (2025-01-01) -
AM1241 inhibits chondrocyte inflammation and ECM degradation through the Nrf2/HO-1 and NF-κB pathways and alleviates osteoarthritis in mice
by: Zhuan Zou, et al.
Published: (2025-01-01) -
Alone or in combination, hyaluronic acid and chondroitin sulfate alleviate ECM degradation in osteoarthritis by inhibiting the NF-κB pathway
by: Yiran Ma, et al.
Published: (2025-01-01)